医药生物行业：养老服务改革深化，关注产业链与科技创新机遇

Investment Rating - The industry investment rating is maintained at "Overweight" [6] Core Insights - The report highlights the release of the "Opinions on Deepening the Reform and Development of Elderly Care Services" by the Central Committee and the State Council, which aims to address population aging and enhance the well-being of the elderly [6] - The report emphasizes the importance of integrating medical and elderly care services, which is expected to create opportunities for companies involved in the elderly care industry [6] - The report suggests that companies focusing on smart elderly care devices, remote medical services, and health big data analysis are likely to benefit from market opportunities [6] Summary by Sections Industry Performance - The industry has shown relative returns of -6.18% over the past month, -7.39% over the past three months, and -28.78% over the past year compared to the CSI 300 index [3] Policy Highlights - The report outlines key tasks such as building comprehensive elderly care service management platforms and enhancing community-based elderly care services [6] - It also mentions the promotion of state-owned capital participation in the elderly care sector and the encouragement of foreign investment in domestic elderly care services [6] Investment Opportunities - The report identifies potential investment opportunities in the elderly care industry, particularly in companies involved in the construction and operation of elderly care facilities, elderly health management, and the development of elderly products [6] - Specific companies to watch include Yuexin Health, Madi Technology, and Yuyue Medical, which are positioned to benefit from the integration of medical and elderly care services [6]